Introduction {#sec1}
============

Primitive hematopoietic progenitors arise from the yolk sac in mammals and generate red blood cells (RBCs), thereby providing oxygen to the rapidly developing embryos ([@bib42]). In zebrafish, equivalent cells arise from the lateral plate mesoderm (LPM), where anteriorly located cells give rise to myeloid cells and posteriorly located cells produce mostly RBCs. The first hematopoietic progenitors appear bilaterally from the 2- to 3-somite stage and express the transcription factor (TF) genes *fli1a*, *scl*, and *lmo2* ([@bib31; @bib61]). By the 5-somite stage, posterior LPM cells are specified to the RBC lineage expressing *gata1* ([@bib9; @bib13]). As embryos develop, these bilateral stripes merge, creating the intermediate cell mass (ICM) region ([@bib13]). By 24 hr postfertilization (hpf), the embryonic RBCs start circulating.

Cdx4, a member of the caudal family, has been linked to embryonic hematopoiesis and leukemogenesis ([@bib3; @bib9; @bib69]). The *Cdx* genes encode homeodomain-containing TFs that are known as master regulators of the *Hox* genes, and help establish the anterior-posterior (A-P) axis ([@bib45; @bib58]). Mammals have three paralogs of the *Cdx* family (*Cdx1*, *Cdx2*, and *Cdx4*) that are expressed in the posterior tissues of the embryo ([@bib79]). Targeted knockout of *Cdx* genes demonstrated their roles in paraxial mesoderm, neurectoderm, and endoderm formation in mice ([@bib8; @bib18; @bib64; @bib66; @bib80]). For example, *Cdx2/4* compound knockout mice show a truncated axial skeleton, decreased presomitic mesoderm, and defective caudal hindgut endoderm and placenta, indicating that *Cdx* genes function redundantly in mesendodermal tissue formation ([@bib66; @bib80]). Zebrafish also have three *cdx* paralogs: *cdx1a*, *cdx1b*, and *cdx4*. *cdx4*^*−/−*^ embryos display shortened tail and neurectoderm defects, which are enhanced when *cdx1a* is also knocked down ([@bib9; @bib11; @bib55]).

Zebrafish *cdx4*^*−/−*^ embryos display a severe anemia, with decreased levels of *scl*, *lmo2*, and *gata1* expression in the posterior LPM ([@bib9]). This function of Cdx4 in hematopoiesis is conserved in murine embryonic stem cells (ESCs), where *Cdx4* overexpression increases erythroid, megakaryocyte, granulocyte, and macrophage lineage formation ([@bib69]). Compound *Cdx* knockout in murine ESCs also leads to failures in hematopoietic differentiation ([@bib70]). In addition to embryonic hematopoiesis, *Cdx* members are implicated in leukemogenesis, as shown by *CDX2* translocations in acute myeloid leukemia (AML) patients, and leukemia seen in mice with *Cdx4* overexpression in bone marrow ([@bib3; @bib54]).

Many of the functions of *Cdx* have been linked to its ability to regulate *Hox* gene transcription ([@bib79]). However, an impact on *Hox* gene regulation does not explain all the defects in *Cdx* mutants. For example, conditional *Cdx2* knockout mice show defects in endoderm and presomitic mesoderm formation independently of *Hox* genes ([@bib18; @bib52]). In addition, overexpression of anterior *hox* genes does not rescue the hindbrain defects seen in *cdx4*^*−/−*^*/cdx1a*^*mo*^ zebrafish ([@bib57]). These results suggest that *Cdx* function cannot be explained solely by *Hox* genes, and there must be other critical downstream genes.

Advances in chromatin immunoprecipitation sequencing (ChIP-seq) technology have helped investigators decipher complex transcriptional networks in many biological systems in a global manner. In ESCs, ChIP-seq experiments revealed that Oct4, Nanog, Sox2, and Sall4 share *cis*-regulatory modules and regulate each other to maintain pluripotency ([@bib32; @bib34]). Similar global studies were conducted in developing *Drosophila* and zebrafish embryos ([@bib37; @bib50; @bib51]). Here, we used a genome-wide approach to identify direct Cdx4 target genes in zebrafish embryos by implementing ChIP-seq and microarray expression profiling. We show that the zinc-finger TF gene *sall4* is a downstream target of Cdx4. ChIP-seq analysis of Sall4 similarly demonstrates that it binds to its own promoter and *cdx4* regulatory elements. Gene-expression studies demonstrate that Cdx4 and Sall4 directly activate *hox* genes and hematopoietic genes. Cdx4 and Sall4 genetically interact during ventral mesoderm development, consistent with a role for these TFs in the early expression of hematopoietic TFs. Together, these results suggest that auto- and cross-regulatory interactions between *cdx4* and *sall4*, as well as coactivation of common gene targets, establish a key regulatory module that directs the transition of the mesoderm into blood.

Results {#sec2}
=======

Identification of Direct Cdx4 Downstream Target Genes {#sec2.1}
-----------------------------------------------------

To identify direct Cdx4 downstream target genes, we conducted ChIP-seq using zebrafish embryos in the bud stage, the stage just prior to the emergence of *fli1a+*, *scl+*, and *lmo2+* hematopoietic progenitors. Since ChIP-quality zebrafish Cdx4 antibodies were not available, a full-length, C-terminally myc-tagged zebrafish Cdx4 was overexpressed and myc antibodies were used for immunoprecipitation. This technique has been used successfully for Nanog ChIP-seq analysis in zebrafish ([@bib78]). To reduce nonspecific Cdx4 binding, *cdx4-myc* mRNA was injected at a dose that rescued *cdx4*^*−/−*^ animals but did not cause morphological changes in *cdx4*^*+/−*^ animals ([Figure S1](#app2){ref-type="sec"}A available online).

Cdx4 ChIP-seq yielded 5,166 binding events, which corresponded to 1,343 proximal genes (distance to the transcriptional start site: ±10 kb). De novo motif analysis using the top 500 bound sequences gave an ATAAA motif, which was reported as the Cdx2 consensus DNA-binding motif ([Figure 1](#fig1){ref-type="fig"}A; [@bib40; @bib67]). The Cdx family members share a highly similar homeodomain and are functionally redundant ([@bib53]). The most well-known targets of the Cdx family members are *Hox* genes ([@bib7; @bib25; @bib58]), and strong Cdx4 binding was found across all seven clusters of *hox* genes in the zebrafish genome ([Figures 1](#fig1){ref-type="fig"}B and [S1](#app2){ref-type="sec"}B). Cdx4 bound to its own locus, suggesting possible autoregulation ([Figure 1](#fig1){ref-type="fig"}C).

Binding to specific signaling pathways and gene programs does not necessarily mean that Cdx4 regulates their transcription at the time of the analysis. To demonstrate that Cdx4 binding to these loci leads to transcriptional changes during the LPM-to-hematopoietic transition, we evaluated gene expression by microarrays. Given the redundancy between Cdx4 and Cdx1a, we used 2-somite stage embryos coinjected with *cdx4* and *cdx1a* morpholinos (*cdx4*^*mo*^*/cdx1a*^*mo*^) because these embryos display the most severe loss-of-Cdx-function phenotype ([@bib11]). To systematically compare the ChIP-seq target list with the microarray data, we ranked differentially regulated genes in the *cdx4*^*mo*^*/cdx1a*^*mo*^ microarray data using the Gene Set Enrichment Analysis (GSEA) and compared them with Cdx4 binding ([@bib59]). This analysis showed that the Cdx4-bound genes were highly downregulated in the *cdx4*^*mo*^*/cdx1a*^*mo*^ microarray (normalized enrichment score \[NES\] = 1.76, false discovery rate \[FDR\] = 0.1; [Figure S1](#app2){ref-type="sec"}C), suggesting that Cdx4 works as a transcriptional activator, consistent with data previously reported with Cdx2 ([@bib40; @bib68]). For example, 26 of the 44 Cdx4-bound *hox* genes and the Cdx4 bound-Wnt pathway genes, including *axin1*, *axin2*, and *wnt5b*, were all downregulated, confirming the Cdx4 ChIP-seq data ([Figure S1](#app2){ref-type="sec"}D). These results suggest that a subset of the Cdx4-binding sites detected by ChIP-seq is indeed transcriptionally regulated by Cdx4.

*sall4* Is a Direct Downstream Target of Cdx4 {#sec2.2}
---------------------------------------------

*spalt-like 4* (*sall4*) was strongly downregulated in *cdx4*^*mo*^*/cdx1a*^*mo*^ and bound by Cdx4 ([Figures 1](#fig1){ref-type="fig"}D and [S1](#app2){ref-type="sec"}E). The *spalt* gene was first identified in *Drosophila*, where its mutation caused homeotic changes in the posterior head and anterior tail region ([@bib15; @bib23]). Its homologs are highly expressed in the developing tail tip region in both chickens and frogs ([@bib4; @bib39]). In addition, *SALL4* transgenic mice develop AML, reminiscent of mice that were transplanted with mCdx4-transduced bone marrow ([@bib3; @bib35]). Because the *cdx* homolog, *caudal*, is involved in homeotic switches in *Drosophila* and is highly enriched in the posterior region, the *sall4* gene made an excellent candidate to act downstream of *cdx4*.

To validate the microarray data indicating that a loss of Cdx function leads to decreased *sall4* transcription, we conducted whole-mount in situ hybridization (WISH) was conducted in 10-somite stage *cdx4*^*mo*^*/cdx1a*^*mo*^ embryos. *sall4* expression was downregulated in these embryos, consistent with the Cdx factors directly regulating *sall4* transcription ([Figure 1](#fig1){ref-type="fig"}E). We also found that *cdx4* and *sall4* are spatially and temporally coexpressed ([Figure S1](#app2){ref-type="sec"}F). Taken together, these results strongly suggest that Cdx4 regulates *sall4* transcription during zebrafish development.

Sall4 Binds to the *cdx4* Locus {#sec2.3}
-------------------------------

To examine Sall4 downstream target genes, we conducted ChIP-seq on bud-stage zebrafish embryos injected with 100 pg of *sall4-myc* mRNA, which does not cause morphological defects ([Figure S1](#app2){ref-type="sec"}G). Sall4 ChIP-seq resulted in 9,747 binding events that corresponded to 1,832 proximal genes. De novo motif analysis gave the ATTTGCAT motif, which is known as the *Oct4* motif ([Figure 1](#fig1){ref-type="fig"}F; [@bib34]). In addition, Sall4-myc bound to the *oct4/pou5f1* locus, consistent with reports showing that Sall4 is a part of the core ESC complex with Oct4 ([Figure 1](#fig1){ref-type="fig"}G; [@bib48; @bib65; @bib77]). Sall4 binds to its own locus, suggesting autoregulation, and to the *cdx4* locus, indicating cross-regulatory interactions between Sall4 and Cdx4 ([Figures 1](#fig1){ref-type="fig"}H and [S1](#app2){ref-type="sec"}H).

Cdx4 and Sall4 Coregulate Genes Responsible for the Mesoderm-to-Blood Transition {#sec2.4}
--------------------------------------------------------------------------------

The Sall4 ChIP-seq analysis showed a substantial overlap in binding sites with Cdx4 across the genome ([Figure 2](#fig2){ref-type="fig"}A). When we compared the Cdx4-Sall4 cobound sites with the bud-stage zebrafish histone ChIP-seq data, we found that 44% of these sites overlapped with H3K27ac-enriched domains, whereas only 1.4% overlapped with H3K4me3-enriched domains. This indicates that Cdx4 and Sall4 cobinding corresponds to active enhancers ([Figure 2](#fig2){ref-type="fig"}B; [@bib46]). A Gene Ontology (GO) analysis of the Cdx4-Sall4 cobound gene list revealed that the cobound group is enriched with genes associated with pattern specification and embryonic morphogenesis ([Figure 2](#fig2){ref-type="fig"}C).

To determine whether Cdx4 and Sall4 cobinding leads to a cooperative transcriptional output, we obtained gene-expression data from *cdx4*^*mo*^, *sall4*^*mo*^, and *cdx4*^*mo*^*/sall4*^*mo*^ embryos. To examine whether knockdown of both genes leads to a greater transcriptional change compared with single knockdowns, we compared the expression level in the double morphants with that in the single morphants (see [Experimental Procedures](#sec4){ref-type="sec"} for details). In both the 3- and 10-somite stage embryos, the double morphants exhibited enhanced down- or upregulation of mRNA expression compared with the single morphants ([Figures 3](#fig3){ref-type="fig"}D and [S2](#app2){ref-type="sec"}A). At the 10-somite stage, the top ten most downregulated genes from double morphants included *hox* genes, indicating that in addition to being cobound to the *hox* gene loci, Cdx4 and Sall4 cooperate to regulate the *hox* gene transcriptional program ([Figure S2](#app2){ref-type="sec"}B). In addition, these double morphants exhibit downregulation of non-hox gene members such as *gfi1.1* and *morc3b* ([Figure S2](#app2){ref-type="sec"}B).

We noted that a number of genes affected in the double morphants were those that are typically associated with primitive hematopoiesis (e.g., *gata1*, *gfi1.1*, and *znfl2*) ([@bib13; @bib16; @bib72]). To globally address whether double morphants show defects in hematopoiesis, we used GSEA to compare the genes affected in *cdx4*^*mo*^*/sall4*^*mo*^ with the gene signatures of hematopoietic cells subjected to fluorescence-activated cell sorting (FACS) or morphants deficient in blood. The gene signature of the fli1a:GFP+ cells (the sorted population from the 10-somite stage Tg(*fli1a:GFP*) that express GFP in both blood and endothelial cells; [@bib28]) was highly enriched in the *cdx4*^*mo*^*/sall4*^*mo*^ gene-expression set (NES = 2.50, FDR = 0.0; [Figure 3](#fig3){ref-type="fig"}D). Genes that were downregulated in the *scl*^*mo*^ (which lacks a hemangioblast population; [@bib14; @bib43]) were also strongly enriched in the *cdx4*^*mo*^*/sall4*^*mo*^ (NES = 1.87, FDR = 0.0; [Figure 3](#fig3){ref-type="fig"}E). To determine whether the *cdx4*^*mo*^*/sall4*^*mo*^enrichment was specific to blood, was conducted additional GSEAs using endothelial ([@bib76]), renal ([@bib41; @bib74; @bib75]), muscle ([@bib12]), and neuron ([@bib30]) gene sets ([Figures S2](#app2){ref-type="sec"}C--S2F). Among these, only the endothelial gene set showed significant enrichment (NES = 2.47, FDR = 0.0; [Figure S2](#app2){ref-type="sec"}C). This result is not surprising, because blood and endothelial populations share common TFs, especially during primitive hematopoiesis ([@bib10]). In contrast, the enrichment scores for other gene sets were not significant, indicating that *cdx4*^*mo*^*/sall4*^*mo*^ embryos show more specific defects in the hemangioblast population ([Figures S2](#app2){ref-type="sec"}D--S2F). Taken together, the ChIP-seq and microarray data indicate that Cdx4 and Sall4 coregulate a set of genes involved in both embryonic pattern formation and primitive hematopoiesis.

*sall4* and *cdx4* Functionally Interact during the Formation of RBCs {#sec2.5}
---------------------------------------------------------------------

To demonstrate that *sall4* functionally interacts with *cdx4* during embryonic hematopoiesis, *sall4* was knocked down in *cdx4*^*−/−*^ embryos. *cdx4*^*+/−*^ zebrafish were crossed and *sall4*^*mo*^ was injected into one-cell-stage embryos ([@bib9; @bib21]). Knockdown of *sall4* in either a *cdx4*^*+/+*^ or *cdx4*^*+/−*^ background resulted in a slight shortening of the A-P axis by 28 hpf, but had no effect on erythropoiesis.

Because *cdx4*^*−/−*^ have fewer *gata1*+ cells in the ICM region and fewer RBCs later, we examined these phenotypes in *sall4* knockdowns in the background of *cdx4*^*+/+*^, *cdx4*^*+/−*^, and *cdx4*^*−/−*^ embryos. At the 18-somite stage, the *cdx4/sall4*^*mo*^ embryos had fewer *gata1*+ cells compared with the uninjected *cdx4*^*−/−*^ embryos ([Figure 3](#fig3){ref-type="fig"}A). The *cdx4*^*+/+*^*/sall4*^*mo*^ or *cdx4*^*+/−*^*/sall4*^*mo*^ embryos did not show a decrease in *gata1*. Although the hematopoietic defect in the *cdx4*^*−/−*^*/sall4*^*mo*^ embryos was not as severe as that shown in the *cdx4*^*mo*^*/cdx1a*^*mo*^ embryos that completely lack *gata1* ([@bib11]), these studies indicate that Sall4 and Cdx4 functionally interact during erythroid progenitor formation ([Figure 3](#fig3){ref-type="fig"}A).

The injected embryos were grown to 3 days postfertilization (dpf), and o-dianisidine staining was conducted to examine hemoglobinized RBCs ([@bib47]). As previously reported ([@bib9]), *cdx4*^*−/−*^ embryos showed a decreased number of hemoglobinized RBCs compared with wild-type or *cdx4*^*+/−*^ embryos. When *sall4*^*mo*^ was injected, these *cdx4*^*−/−*^ embryos showed even fewer hemoglobinized RBCs, consistent with *sall4* cooperating with *cdx4* during erythropoiesis ([Figure 3](#fig3){ref-type="fig"}B, arrow). The posterior mesoderm was also critically affected in *cdx4*^*−/−*^*/sall4*^*mo*^ embryos, as evidenced by the size of the tail ([Figure S3](#app2){ref-type="sec"}).

Loss of *scl* and *lmo2* Is Responsible for the Lack of RBCs in *cdx4*^*−/−*^*/sall4*^*mo*^ Embryos {#sec2.6}
---------------------------------------------------------------------------------------------------

The loss of RBCs seen in the *cdx4*^*−/−*^*/sall4*^*mo*^ embryos could be caused by an earlier defect in LPM differentiation. The TF Scl and its cofactor Lmo2 are key determinants of hematopoietic precursors that are expressed as bilateral stripes in the LPM at the 3-somite stage ([@bib31; @bib61]). Loss of *scl* or *lmo2* in the zebrafish leads to a lack of RBCs ([@bib14; @bib43; @bib44]). At the 10-somite stage, *cdx4*^*−/−*^ embryos displayed only a few posterior *scl+* and *lmo2+* cells, whereas *cdx4*^*−/−*^*/sall4*^*mo*^ embryos showed no detectable *scl* or *lmo2* expression ([Figure 4](#fig4){ref-type="fig"}A). This suggests that early hematopoietic progenitors do not form properly in *cdx4*^*−/−*^*/sall4*^*mo*^ embryos. In contrast, *cdx4*^*mo*^*/sall4*^*mo*^ embryos have *fli1a+* and *draculin*+ cells in the LPM, indicating that the general lateral mesoderm is present in these embryos. *myoD* (somite), *pax2a* (kidney), and *tbx16* (presomitic mesoderm) expression is minimally affected, showing that *cdx4* and *sall4* specifically affect early hematopoietic progenitors ([Figure 4](#fig4){ref-type="fig"}B; [@bib24; @bib36; @bib73]). In accordance with a putative regulatory role in *scl* and *lmo2* transcription, both the Cdx4 and Sall4 ChIP-seq profiles showed both factors binding near the *scl* and *lmo2* loci, which was confirmed by ChIP-PCR analysis ([Figures 5](#fig5){ref-type="fig"}C, 5D, and [S4](#app2){ref-type="sec"}).

To determine whether this early block in *scl* and *lmo2* expression is responsible for the RBC loss in *cdx4*^*−/−*^*/sall4*^*mo*^ embryos, we overexpressed *scl* and *lmo2* in transgenic zebrafish carrying the globin *lcr:GFP* reporter ([@bib17]; [Figure 5](#fig5){ref-type="fig"}A). The *scl* and *lmo2* genes, together with a control plasmid, were driven under the control of the *ubi* promoter ([@bib38]) and injected into *cdx4*^*mo*^*/sall4*^*mo*^*/Tg*(*lcr:GFP*) embryos. The *ubi:mCherry* plasmid was used as an additional control to assess injection mosaicism. As expected, injection of these plasmids led to ubiquitous expression of transgenes ([Figure S5](#app2){ref-type="sec"}). In line with our previous results, *cdx4*^*mo*^*/sall4*^*mo*^*/Tg*(*lcr:GFP*) embryos lacked *lcr:GFP* expression, which could not be rescued with control plasmid injection or *ubi:scl* injection ([Figure 5](#fig5){ref-type="fig"}B, top and middle rows). In contrast, *ubi:scl*;*ubi:lmo2* double injection in *cdx4*^*mo*^*/sall4*^*mo*^ embryos led to *lcr:GFP* expression in the ICM (n = 9/21; [Figure 5](#fig5){ref-type="fig"}B, bottom row), as well as *gata1* expression (n = 23/49; [Figure 5](#fig5){ref-type="fig"}C), indicating that *scl* and *lmo2* can rescue the erythropoietic defects caused by Cdx4 and Sall4 deficiency. Taken together, these results reveal that *cdx4* and *sall4* genetically interact in a regulatory circuit involving cross- and autoregulation to control the expression of TFs involved in mesodermal and hematopoietic lineage specification.

Discussion {#sec3}
==========

Our findings illustrate a transcriptional circuit involving Cdx4 and Sall4 that is required for the developmental transition from mesoderm to blood formation in zebrafish. By integrating ChIP-seq and expression profiling data from zebrafish embryos, we show that Sall4 shares multiple common target genes with Cdx4, including the TFs themselves, *hox* genes, *scl*, and *lmo2*. Consistent with this finding, the *cdx4*^*−/−*^*/sall4*^*mo*^ embryos exhibit enhanced defects in embryonic hematopoiesis compared with *cdx4*^*−/−*^ embryos, which can be overcome by *scl* and *lmo2* overexpression.

*sall4* deficiency alone does not affect embryonic erythropoiesis, but it cooperates with the *cdx4* mutant phenotype as shown by microarray, loss of RBCs, and severe tail truncation ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [S2](#app2){ref-type="sec"}A, and [S3](#app2){ref-type="sec"}). Similarly, the *cdx1a*^*mo*^ has a mild phenotype, but *cdx4*^−/−^*/cdx1a*^*mo*^ embryos show a more severe axial truncation and a complete loss of erythropoiesis compared with *cdx4*^−/−^ ([@bib11]). This finding is attributed to redundancy between Cdx1a and Cdx4, given that Cdx paralogs compensate for each other ([@bib53]). Sall4 shares activities with the Cdx factors, and Sall4 binding likely enhances the transcriptional activity of Cdx-containing complexes on cobound target genes ([Figure 2](#fig2){ref-type="fig"}). Sall4 activates target genes synergistically with other TFs, such as Tcf4 and beta-catenin in gastrula-stage mouse embryos, and with Tbx5 in the heart and forelimb field ([@bib26; @bib63]). In addition, Sall4 physically binds with Cdx2 in murine ESCs ([@bib40]), potentially supporting a model whereby Cdx factors and Sall4, each bound to their respective DNA consensus motifs on common targets, are able to form an enhanceosome ([@bib40]). Our ChIP-seq data demonstrate cobinding on DNA, suggesting that this interaction regulates the transition from mesoderm to the blood lineage.

The transcriptional program in the mesoderm adapts to the progressive development of the final descendant organs. During zebrafish development, *cdx4* is highly expressed in the future mesodermal progenitor cells during the early gastrula stage, and its expression overlaps with that of hematopoietic genes at the 3-somite stage. By the 5-somite stage, *cdx4* is expressed in the paraxial mesoderm, diverging from that of hematopoietic genes. Our ChIP-seq result suggests that during the gastrula stage, a Cdx4-Sall4 circuit regulates genes (e.g., *hox* genes) that drive cells to adopt a posterior mesodermal fate, which by the late gastrula stage allows Cdx4 to drive the expression of hematopoietic genes ([Figure 2](#fig2){ref-type="fig"}). Although the mild decrease in the expression of nonhematopoietic genes such as *pax2a* and *tbx16* in *cdx4*^*mo*^*/sall4*^*mo*^ embryos raises the question as to whether *cdx4* and *sall4* specifically affect hematopoietic tissues, these embryos still have a normal amount of *fli1a+ draculin+* cells, indicating that the LPM formation is normal ([Figure 4](#fig4){ref-type="fig"}).

*Scl* and *Lmo2* are key hematopoietic TFs whose deficiency cause severe anemia ([@bib14; @bib43; @bib56; @bib71]). As *scl* overexpression could not rescue the *gata1* loss seen in *cdx4*^−/−^, it has been hypothesized that Cdx4 acts to make the posterior mesoderm competent to respond to genes that specify the hematopoietic fate ([@bib9]). An alternative model would include the possibility that other Cdx4 target genes participate in hematopoietic induction. One intriguing possibility is that Scl is insufficient to rescue the *cdx4*^−/−^ because it lacks the Scl cofactor, Lmo2. Our ChIP-seq and ChIP-PCR data demonstrate that *scl* and *lmo2* genes are bound by Cdx4 and Sall4, and expression of *scl* and *lmo2* is reduced in *cdx4*^*−/−*^*/sall4*^*mo*^ ([Figures 4](#fig4){ref-type="fig"}A, 4C, 4D, and [S4](#app2){ref-type="sec"}). Our rescue data show that *scl* in combination with *lmo2* can drive erythropoiesis genes in the *cdx4*^*mo*^*/sall4*^*mo*^, indicating that *lmo2* is another key factor that is responsible for the loss of RBCs ([Figure 5](#fig5){ref-type="fig"}). The lack of *gata1* rescue to the wild-type level shows that there could be other additional Cdx4 and Sall4 targets. A recent ChIP study showed that *Lmo2* transcription in hematopoietic cells is regulated by HoxA9 ([@bib22]). Our results suggest that Cdx4 and Sall4 regulate *hoxa9a* transcription in zebrafish ([Figure S2](#app2){ref-type="sec"}B). This suggests that *lmo2* could be regulated in a tightly controlled manner during the differentiation of LPM to blood, directly by Cdx4 and Sall4, and secondarily by another Cdx4 and Sall4 target gene, Hoxa9a. We speculate that this type of transcriptional loop ensures a robust activation of the blood program.

Our ChIP-seq data indicate that Cdx4 and Sall4 engage in auto- and cross-regulatory loops. Such regulatory circuits are frequently seen during embryonic development. For example, during segmentation of rhombomere 4 in the mouse hindbrain, retinoic acid signaling first turns on *HoxB1*, followed by *HoxB1*, *HoxB2*, and *HoxA2*, maintaining their expression through tight auto- and cross-regulatory loops ([@bib1; @bib19; @bib62]). The Cdx4-Sall4 circuit during zebrafish development may function in an analogous way with upstream regulators such as Wnt, BMP, and FGF, activating expression of Cdx4 and Sall4, followed by the stabilization of their expression by auto- and cross-regulatory loops. We hypothesize that a stable Cdx4-Sall4 circuit is required to make the mesoderm competent for the specification of posterior tissue lineages such as blood by turning on the hematopoietic master TFs Scl and Lmo2 ([Figure 6](#fig6){ref-type="fig"}).

Our current model also gives insights into leukemogenesis. Previously, Hox gene misregulation was the main focus of attempts to understand the mechanism behind Cdx genes causing leukemia ([@bib3; @bib54]). Our current model suggests another possibility, i.e., that Cdx genes directly regulate Scl and Lmo2. As mutation of both of these genes has been linked to various leukemias, such as T cell acute lymphoblastic leukemia ([@bib5; @bib6; @bib49]), the model raises the possibility that these two genes may be aberrantly regulated in leukemias that are caused by Cdx or Sall4 mutation.

In conclusion, our data establish a Cdx4-Sall4 circuit that acts in the posterior mesoderm to facilitate blood cell formation and axial elongation. We propose that during the early gastrula stage, Cdx4 and Sall4 are activated by upstream regulators such as Wnt, and their auto- and cross-regulation act to stabilize the mesoderm state. At the end of gastrulation, Cdx4 and Sall4 bind to *scl* and *lmo2* to induce the hematopoietic program in the mesoderm. As upstream signaling dissipates, the Cdx4-Sall4 regulatory loops are disrupted, with a concomitant reduction in *cdx4* and *sall4* expression, and further blood differentiation is driven by factors such as Scl and Lmo2 ([Figure 6](#fig6){ref-type="fig"}). This model is likely applicable to the formation of other tissues and provides a molecular framework to understand how Cdx and Sall factors induce leukemia.

Experimental Procedures {#sec4}
=======================

Zebrafish {#sec4.1}
---------

Zebrafish were maintained according to Institutional Animal Care and Use Committee guidelines. The Animal Care and Use Committee of Boston Children's Hospital approved all of the animal protocols. Wild-type (Tu) and *cdx4*^*+/−*^ incrossed embryos were collected at the one-cell stage and injected with mRNA or morpholino for further experiments.

ChIP {#sec4.2}
----

ChIP was performed as previously described ([@bib29; @bib33]). For detailed information, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}. myc (abcam ab9132), H3K4me3 (Millipore 07-473), and H3K27ac (abcam ab4729) antibodies were used at 5 μg per ChIP sample.

ChIP-Seq Analysis {#sec4.3}
-----------------

Sequence reads were aligned to the genome (danRer6) using Bowtie version 0.12.7 with options "-q--best--strata -m 1 -p 4--chunkmbs 1024" ([@bib27]). Only uniquely mapping reads were analyzed further. Binding events were detected using GPS as previously described ([@bib20]). For detailed information on ChIP-seq analysis, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}. The ChIP-seq data have been deposited in the GEO database under accession number [GSE48254](ncbi-geo:GSE48254){#intref0010}.

ChIP-PCR Analysis {#sec4.4}
-----------------

Primers were designed for *cdx4*, *sall4*, *scl*, and *lmo2* loci (listed in [Table S1](#app2){ref-type="sec"}). Quantities are expressed as fold change compared with input controls.

Morpholinos {#sec4.5}
-----------

One-cell-stage embryos were injected with *sall4*^*mo*^ (2 ng; [@bib21]), *cdx4*^*mo*^ (1.5 ng), or *cdx1a*^*mo*^ (0.5 ng).

mRNA {#sec4.6}
----

*cdx4* and *sall4* cDNA was described previously ([@bib9; @bib21]). mRNA was generated by the mMessage mMachine kit and injected into one-cell-stage embryos.

Microarray Analysis {#sec4.7}
-------------------

Embryos were injected with either *cdx4* or *sall4*, or both morpholinos together. Injected embryos, along with uninjected control embryos, were harvested at the 3- or 10-somite stage and RNA was prepared for microarray. For the arrays in these experiments, we used the prerelease Affymetrix Zebrafish 2.0 array, which was developed in the Zon laboratory in cooperation with Affymetrix. The *cdx4*^*mo*^*/cdx1a*^*mo*^ data set was generated on the Affymetrix Zebrafish 1.0 array. Detailed information on microarray analysis can be found in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

GSEA Analysis {#sec4.8}
-------------

### Enrichment of Cdx4-Bound Genes in the cdx4/cdx1a Double-Morphant Gene-Expression Set {#sec4.8.1}

The fli1a:GFP or *scl*^*mo*^ gene lists were used as input to GSEA for queries into the entire *cdx4*^*mo*^*/sall4*^*mo*^ microarray data set. In this case, because the *cdx4*^*mo*^*/sall4*^*mo*^ arrays were performed using the Zebrafish Affymetrix 2.0 arrays, we used the Zv9 gene identifier as the input for GSEA. For endothelial, kidney, muscle, and neuron gene sets, the annotated gene list was probed. Enrichment of the double morphant compared with control embryos was calculated using the NES and FDR as described above. Detailed information regarding the gene list sources can be found in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

WISH and o-Dianisidine Staining {#sec4.9}
-------------------------------

WISH and o-dianisidine staining were performed as previously described ([@bib47; @bib60]). The *gata1*, *sall4*, *scl*, *lmo2*, *fli1a*, *myoD*, *draculin*, *pax2a*, *tbx16*, and *morc3b* probes were described in previous publications ([@bib13; @bib24; @bib31; @bib36; @bib61; @bib73]).

DNA Injection {#sec4.10}
-------------

For DNA injection, 1 nl of a 16 ng/μl DNA mixture was injected into one-cell-stage embryos. For detailed information on the plasmids used, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"} and [Table S2](#app2){ref-type="sec"}.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S5, and Tables S1 and S2

We thank members of the Zon laboratory for helpful discussions, J. Ganis for providing *Tg(lcr:GFP)*, and M. Logan for providing the *sall4* cDNA construct. We also thank the Whitehead Genome Technology Core for data production and analysis support. Microarray studies were performed by the Molecular Genetics Core Facility at Children's Hospital Boston, supported by NIH grants P50-NS40828 and P30-HD18655. This work was supported by grants from the NHLBI (5R01HL048801-21 to L.I.Z. and 5P01HL32262-31), NIDDK (5P30 DK49126-19, DK53298-15, and R24 DK092760-02), and HHMI (to L.I.Z.). L.I.Z. is a founder and stockholder of Fate, Inc., and Scholar Rock, and a scientific advisor for Stemgent.

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

![Cdx4 and Sall4 Bind to Each Other's Genomic Locus\
(A) Cdx4-binding sites are enriched for the ATAAA motif. The most enriched motif was identified using MEME ([@bib2]).\
(B) Gene track of the *hox aa* locus, showing Cdx4 binding at genomic regions along the x axis and the total number of reads on the y axis.\
(C) Gene track of the *cdx4* locus, showing Cdx4 binding to its own locus.\
(D) Gene track of the *sall4* locus, showing Cdx4 binding to *sall4* locus.\
(E) WISH of *sall4* mRNA expression level in 10-somite stage wild-type embryos and *cdx4*^*mo*^*/cdx1a*^*mo*^. Scale bar = 200 μm.\
(F) Sall4-binding sites are enriched for the ATTTGCAT motif, an *Oct4* motif.\
(G) Gene track of the *pou5f1* locus, showing Sall4 binding.\
(H) Gene track of *sall4* and *cdx4* loci, showing Sall4 binding.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![Cdx4 and Sall4 Coregulate Downstream Target Genes\
(A) Genome-wide Cdx4 and Sall4 binding events. The two columns show enrichment over all Sall4 and Cdx4 binding sites, where the blue shading corresponds to the ChIP-seq read count in the region.\
(B) Cdx4- and Sall4-bound regions are associated with H3K27ac histone marks. The bar graph shows the relative overlap of Cdx4-bound, Sall4-bound, and Cdx4-Sall4-cobound regions with H3K27ac (enhancer) and H3K4me3 (promoter) marks compared with background expectation. The overlap enrichment score calculates the percentage of bound sites that overlap (or are within 100 bp of) a chromatin mark domain and normalizes by the percentage of 10,000 random genomic sites that overlap (or are within 100 bp of) the same chromatin mark domains.\
(C) GO Analysis of the Cdx4-Sall4 Cobound Genes\
(D) Heatmap demonstrating the top 1,000 genes that show cooperation between the *cdx4* and *sall4* knockdown at the 10-somite stage. Genes that are only moderately affected in either single morphant show significantly greater effects in the 10-somite stage *cdx4*^*mo*^*/sall4*^*mo*^.\
(E and F) GSEA-based comparison between *cdx4*^*mo*^*/sall4*^*mo*^ and known hematopoietic gene signatures.\
(E) Comparison between *cdx4/sall4* and the GFP+ population from t10-somite stage Tg(*fli1a:GFP*) embryos.\
(F) Comparison with genes downregulated in the 5-somite stage *scl*^*mo*^. In both cases, the hematopoietic signature is strongly enriched in *cdx4*^*mo*^*/sall4*^*mo*^ compared with control embryos.\
See also [Figure S2](#app2){ref-type="sec"}.](gr2){#fig2}

![*sall4* Cooperates with *cdx4* in Zebrafish Hematopoiesis\
(A) *gata1* WISH of 18-somite-stage wild-type or *cdx4*^*−/−*^ embryos that were uninjected or *sall4*^*mo*^ injected. *sall4* knockdown in the *cdx4*^*−/−*^ background leads to a decrease in *gata1+* cells (note the high-powered view).\
(B) o-Dianisidine staining of 3 dpf wild-type or *cdx4*^*−/−*^ embryos that were uninjected or *sall4*^*mo*^ injected. *cdx4*^*−/−*^*/sall4*^*mo*^ embryos have fewer hemoglobinized RBCs. Arrows point to the stained RBCs in the embryos. Scale bar, 200 μm.\
See also [Figure S3](#app2){ref-type="sec"}.](gr3){#fig3}

![*scl* and *lmo2* Are Responsible for the Loss of RBCs Seen in *cdx4*^*−/−*^*;sall4*^*mo*^ Embryos.\
(A and B) *scl* (A) and *lmo2* (B) WISH at the 10-somite stage wild-type or *cdx4*^*−/−*^ embryos that are either uninjected or *sall4*^*mo*^ injected. Embryos were flat-mounted, with the anterior end pointing to the left and the posterior end pointing to the right.\
(C) *fli1a*, *draculin*, *pax2a*, *myoD*, and *tbx16* WISH in 10-somite stage wild-type, *cdx4*^*mo*^, *sall4*^*mo*^, *cdx4*^*mo*^*/sall4*^*mo*^ embryos. All scale bars, 200 μm.\
(D and E) Gene track of the *scl* (D) and *lmo2* (E) loci, showing Cdx4 and Sall4 binding.\
See also [Figure S4](#app2){ref-type="sec"}.](gr4){#fig4}

![Overexpression of *scl* and *lmo2* Rescues the Loss of RBCs in the *cdx4*^*mo*^*/sall4*^*mo*^ Embryos\
(A) DNA-mediated overexpression scheme using Tg(*lcr:GFP*) embryos that express GFP in *globin*+ RBCs. When the embryos reached the 18-somite stage, mCherry+ embryos were selected and their GFP expression and *gata1* expression were examined.\
(B) *cdx4*^*mo*^*/sall4*^*mo*^*/Tg(lcr:GFP)* embryos that were control plasmid injected (top), *ubi:sc*l injected (middle), or *ubi:scl; ubi:lmo2* injected (bottom). The mCherry+ cells show the mosaicism. Note the GFP+ cells in the ICM (white arrow) in the bottom row. The numbers indicate the number of embryos with GFP signal in the ICM.\
(C) *gata1* WISH of embryos shown in (B). The numbers indicate the number of embryos with *gata1* signal in the ICM.\
All scale bars, 200 μm. See also [Figure S5](#app2){ref-type="sec"}.](gr5){#fig5}

![Model\
Cdx4 and Sall4 autoregulate and cross-regulate each other (Sall4-to-Cdx4 regulation is dotted because it is unclear whether Sall4 regulates Cdx4 transcription). They regulate the LPM-to-blood transition in two ways: (1) they regulate *hox* genes for mesoderm specification, and (2) they regulate *scl* and *lmo2* for blood specification.](gr6){#fig6}
